Insider Trading & Executive Data
Start Free Trial
108 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.
National HealthCare Corporation (NHC) is a vertically integrated post-acute and senior care operator that runs skilled nursing facilities, assisted and independent living communities, home health and hospice agencies, and a small behavioral health hospital footprint, supplemented by pharmacy, captive insurance and management services. As of year‑end 2024 NHC operated 80 SNFs (10,341 licensed beds), 26 assisted living communities, 9 independent living communities, 34 homecare agencies and 33 hospice agencies, and generated ~95.7% of revenues from healthcare services with a payor mix of ~33% Medicare, 29% Medicaid and 28% private pay. Recent strategic activity includes the August 1, 2024 White Oak acquisition (15 SNFs, 2 AL, 4 IL) and materially higher per‑diems and occupancy (composite SNF per diem +6.8% in 2024; SNF occupancy ~88.6%), while regulatory drivers include FY2025/FY2026 CMS rate actions and phased minimum nurse‑staffing mandates.
Compensation is likely tied to a blend of financial and clinical performance measures that reflect NHC’s operating model—key drivers being adjusted net income/adjusted EPS, operating cash flow, per‑diem rate realization, SNF occupancy and margin improvement (including reductions in agency nursing expense). Given management’s repeated use of non‑GAAP metrics in disclosures, annual cash incentives and bonus targets are likely calibrated to adjusted results (excluding one‑time acquisition and investment mark‑to‑market items) and integration milestones for acquisitions like White Oak. Long‑term pay typically includes equity (restricted stock/RSUs and/or performance shares) to align executives with total shareholder return and multi‑year quality goals (e.g., CMS star ratings and rehospitalization/clinical metrics); workforce and retention concerns (high wage/benefit spend ~62% of revenues) mean retention bonuses, tuition reimbursement and other non‑cash retention measures are also important. Regulatory and actuarial uncertainties (self‑insurance reserves, professional liability accruals) create scope for comp plan clawbacks or performance adjustments and may lead the board to emphasize cash flow and reserve management in incentive design.
Insiders’ trading patterns at NHC are likely influenced by discrete operational catalysts (M&A activity such as the White Oak acquisition), periodic CMS and state Medicaid rate announcements, and quarter/annual earnings that hinge on occupancy and per‑diem trends. Watch for insider purchases when occupancy, per‑diems and agency cost improvements accelerate (a bullish signal), and for sizable insider sales around acquisition closings, dividend/share‑repurchase communications or ahead of financing actions; conversely, reductions in reserves or adverse litigation/cybersecurity events could prompt sales or defensive disclosure. Because healthcare is highly regulated, expect routine blackout periods around Form 10‑Q/10‑K and material rulemaking announcements, broad use of 10b5‑1 plans among executives, and careful linking of reported non‑GAAP adjustments to incentive outcomes—traders should monitor Section 16 filings closely around reimbursement rule changes, state Medicaid decisions, and large integration milestones.